Additional information
Appearance
Pale yellow Powder
Category
Pharmaceutical Impurity Standards
CAS No.
1246213-23-9
Catalogue No.
ACI-092513
Chemical Name
N-[2-(1,1-Dimethylethyl)-5-hydroxy-4-(2-hydroxy-1,1-dimethylethyl)phenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
IUPAC Name
N-[2-(1,1-Dimethylethyl)-5-hydroxy-4-(2-hydroxy-1,1-dimethylethyl)phenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
Melting Point
NA
Molecular Formula
C24H28N2O4
Molecular Weight
408.49
Shipping Condition
Ambient
Storage Condition
2-8°C
Synonyms
N-(2-(Tert-butyl)-5-hydroxy-4-(1-hydroxy-2-methylpropan-2-yl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
Therapeutic Category
cystic fibrosis
![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)
